|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Product

LEND: Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.

Center:

OR-Oregon Institute on Development & Disability, UCEDD/LEND

Fiscal Year:

2023

Contact Information:

Kristin Knight
[email protected]
503-494-2061

Product Description:

Commentary regarding the FDA approval of sodium thiosulfate for prevention of hearing loss from cisplatin in children aged 1 month to 18 years. The paper was developed to help clinicians understand why STS approval was restricted to localized cancer, how and provide guidance for the use of STS in the future.

Keyword(s):

childhood cancer, children, cisplatin, hearing loss, sodium thiosulfate

Product/Publication Type(s):

Peer-reviewed publications in scholarly journals Published/In Press

Target Audience:

Professionals, Policymakers, Students

Alternative Format:

Electronic (disc, CD, 508 compliant web posting)

To Obtain Copies (URL or Email):

https://onlinelibrary.wiley.com/doi/10.1002/pbc.30248

COVID-19 Related Data:

N/A